These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24994631)

  • 41. The agony of the ecstasy: serotonin and obstructive sleep apnea.
    Chamberlin NL; Saper CB
    Neurology; 2009 Dec; 73(23):1947-8. PubMed ID: 19955498
    [No Abstract]   [Full Text] [Related]  

  • 42. [MDMA ("Ecstasy")--a dangerous drug or psychotherapeutic drug?].
    Szukaj M
    Nervenarzt; 1994 Nov; 65(11):802-5. PubMed ID: 7816160
    [TBL] [Abstract][Full Text] [Related]  

  • 43. What is the evidence that Ecstasy (MDMA) can cause Parkinson's disease?
    Kish SJ
    Mov Disord; 2003 Nov; 18(11):1219-23. PubMed ID: 14639660
    [No Abstract]   [Full Text] [Related]  

  • 44. Ecstasy: towards an understanding of the biochemical basis of the actions of MDMA.
    Rattray M
    Essays Biochem; 1991; 26():77-87. PubMed ID: 1685707
    [No Abstract]   [Full Text] [Related]  

  • 45. [Changes in the energy status of the brain structures in pharmacological exposures].
    Arkhipov VI; Bulantsev AIu
    Farmakol Toksikol; 1986; 49(3):115-9. PubMed ID: 2873050
    [No Abstract]   [Full Text] [Related]  

  • 46. Quantitative mapping shows that serotonin rather than dopamine receptor mRNA expressions are affected after repeated intermittent administration of MDMA in rat brain.
    Kindlundh-Högberg AM; Svenningsson P; Schiöth HB
    Neuropharmacology; 2006 Sep; 51(4):838-47. PubMed ID: 16820177
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [MDMA or ecstasy: pharmacologic, toxicologic and clinical aspects].
    Prada C; Alvarez FJ
    Med Clin (Barc); 1996 Oct; 107(14):549-55. PubMed ID: 8999216
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effects of ecstasy on the body].
    Saarijärvi S; Lopperi M
    Duodecim; 2003; 119(13):1211-5. PubMed ID: 12908183
    [No Abstract]   [Full Text] [Related]  

  • 49. The biologic basis of posttraumatic stress.
    van der Kolk BA; Fisler RE
    Prim Care; 1993 Jun; 20(2):417-32. PubMed ID: 8356161
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prazosin for the treatment of posttraumatic stress disorder sleep disturbances.
    Miller LJ
    Pharmacotherapy; 2008 May; 28(5):656-66. PubMed ID: 18447662
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Ecstasy--effects and toxicity. Distinct risks but uncertain long-term hazards].
    Series H; Lindefors N
    Lakartidningen; 1993 Aug; 90(32-33):2648-52. PubMed ID: 8103135
    [No Abstract]   [Full Text] [Related]  

  • 52. A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD).
    Oehen P; Traber R; Widmer V; Schnyder U
    J Psychopharmacol; 2013 Jan; 27(1):40-52. PubMed ID: 23118021
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New drug development for post-traumatic stress disorder.
    Berlant J
    Curr Opin Investig Drugs; 2003 Jan; 4(1):37-41. PubMed ID: 12625026
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder.
    Strawn JR; Geracioti TD
    Depress Anxiety; 2008; 25(3):260-71. PubMed ID: 17354267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gene expression of catecholaminergic receptors in the central nervous system of hypertensive rats.
    Castellano M; Handy DE; Beschi M; Wang YX; Agabiti-Rosei E; Gavras H
    J Hypertens Suppl; 1991 Dec; 9(6):S54-5. PubMed ID: 1819011
    [No Abstract]   [Full Text] [Related]  

  • 56. [Premeditated ecstasy?].
    Bálint GS
    Orv Hetil; 2003 Apr; 144(14):653-6. PubMed ID: 12795026
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ecstasy toxicity: a comparison to methamphetamine and traumatic brain injury.
    Warren MW; Kobeissy FH; Liu MC; Hayes RL; Gold MS; Wang KK
    J Addict Dis; 2006; 25(4):115-23. PubMed ID: 17088231
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PTSD and carbamazepine.
    Lipper S
    Am J Psychiatry; 1988 Oct; 145(10):1322-3. PubMed ID: 3048124
    [No Abstract]   [Full Text] [Related]  

  • 59. MDMA as a clinical tool: a note of caution. A response to Sessa and Nutt.
    Green A; Marsden C; Fone K
    J Psychopharmacol; 2008 Nov; 22(8):929-31. PubMed ID: 18562430
    [No Abstract]   [Full Text] [Related]  

  • 60. Discrete regional distribution of biochemical markers for the dopamine, noradrenaline, serotonin, GABA and acetylcholine systems in the monkey brain (Cebus Apella). Effects of stress.
    Häggström JE; Sjöquist B; Eckernäs SA; Ingvast A; Gunne LM
    Acta Physiol Scand Suppl; 1984; 534():1-27. PubMed ID: 6150601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.